Treating thrombosis in the 21st century.
Shapiro
Sandor S
SS
D000925:Anticoagulants / Q000266:history / Q000627:therapeutic use*; D001384:Azetidines / Q000627:therapeutic use*; D001596:Benzylamines; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D000077425:Fondaparinux; D006493:Heparin / Q000266:history / Q000627:therapeutic use; D049673:History, 20th Century; D006801:Humans; D011134:Polysaccharides / Q000627:therapeutic use*; D011355:Prodrugs / Q000627:therapeutic use; D013927:Thrombosis / Q000188:drug therapy* / Q000266:history; D014859:Warfarin / Q000266:history / Q000627:therapeutic use
D000925:Anticoagulants; D001384:Azetidines; D001596:Benzylamines; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D011134:Polysaccharides; D011355:Prodrugs; C426686:ximelagatran; D014859:Warfarin; D006493:Heparin; D000077425:Fondaparinux